Baxter International Inc.

NYSE:BAX Stock Report

Market Cap: US$11.8b

Baxter International Future Growth

Future criteria checks 3/6

Baxter International is forecast to grow earnings and revenue by 44.5% and 3.7% per annum respectively. EPS is expected to grow by 42.9% per annum. Return on equity is forecast to be 14% in 3 years.

Key information

44.5%

Earnings growth rate

42.94%

EPS growth rate

Medical Equipment earnings growth13.5%
Revenue growth rate3.7%
Future return on equity13.98%
Analyst coverage

Good

Last updated07 Oct 2025

Recent future growth updates

Recent updates

Baxter International: Medical Business In Need Of A Save Itself

Sep 29

Baxter International Inc.'s (NYSE:BAX) Shares Lagging The Industry But So Is The Business

Jun 21
Baxter International Inc.'s (NYSE:BAX) Shares Lagging The Industry But So Is The Business

Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden

May 02
Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden

Baxter: Messy, Yet Appealing, If New Management Can Deliver

Apr 21

Baxter International (NYSE:BAX) Will Pay A Dividend Of $0.17

Feb 21
Baxter International (NYSE:BAX) Will Pay A Dividend Of $0.17

Baxter International: An Uncompelling Investment With High Debt

Jan 31

Does Baxter International (NYSE:BAX) Have A Healthy Balance Sheet?

Jan 27
Does Baxter International (NYSE:BAX) Have A Healthy Balance Sheet?

Baxter- Reiterating Our Buy Rating After A Promising Q2

Aug 07

Baxter: Why Investors Should Take Advantage Of The Low Valuation

Jul 16

Baxter International: Shares Too Cheap, EPS Growth Ahead With A Possible Spinoff

May 08

Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts

Feb 23

Baxter International: A Cheap Big Pharma Stock With Improving Earnings And +3% Dividend Yield

Dec 12

Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial?

Oct 12

Earnings and Revenue Growth Forecasts

NYSE:BAX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202712,1017431,1161,48510
12/31/202611,7345981,0291,38114
12/31/202511,3162838391,17414
6/30/202510,887-247218765N/A
3/31/202510,771-277191663N/A
12/31/202410,636-3375591,019N/A
9/30/202410,6093716471,062N/A
6/30/202410,5093488851,174N/A
3/31/20249,3371791,0291,410N/A
12/31/202310,3601741,2901,726N/A
9/30/202311,379961,1081,634N/A
6/30/202312,389-2,9328851,559N/A
3/31/202314,461-2,6738371,482N/A
12/31/202210,057-3,1255761,211N/A
9/30/202214,275-2,5687921,465N/A
6/30/202213,8928761,1591,850N/A
3/31/202213,3969921,3412,053N/A
12/31/202112,1461,0221,5312,222N/A
9/30/202112,4511,2141,4962,241N/A
6/30/202112,1971,1201,3542,076N/A
3/31/202111,8171,0681,2651,973N/A
12/31/202011,6731,1021,1591,868N/A
9/30/202011,5319111,2361,985N/A
6/30/202011,4109241,4162,176N/A
3/31/202011,5269911,4872,248N/A
12/31/201911,3621,0011,4082,104N/A
9/30/201911,1561,3351,2011,984N/A
6/30/201911,0661,4849811,739N/A
3/31/201911,0601,505N/A1,698N/A
12/31/201811,0991,552N/A2,017N/A
9/30/201811,0631,065N/A1,699N/A
6/30/201811,009795N/A1,848N/A
3/31/201810,763840N/A2,095N/A
12/31/201710,584609N/A1,714N/A
9/30/201710,4321,025N/A2,036N/A
6/30/201710,283904N/A1,963N/A
3/31/201710,2631,852N/A2,176N/A
12/31/201610,1634,966N/A1,654N/A
9/30/201610,1214,909N/A1,665N/A
6/30/201610,0504,784N/A1,388N/A
3/31/20169,9403,646N/A1,342N/A
12/31/20159,968393N/A1,771N/A
9/30/201510,154337N/A2,190N/A
6/30/201510,376510N/A2,849N/A
3/31/20159,27484N/A2,752N/A
12/31/201410,719457N/A3,215N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BAX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.1%).

Earnings vs Market: BAX is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: BAX is expected to become profitable in the next 3 years.

Revenue vs Market: BAX's revenue (3.7% per year) is forecast to grow slower than the US market (10.1% per year).

High Growth Revenue: BAX's revenue (3.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: BAX's Return on Equity is forecast to be low in 3 years time (14%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/27 00:06
End of Day Share Price 2025/10/27 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Baxter International Inc. is covered by 38 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Matthew TaylorBarclays
Matthew MiksicBarclays